Effects of soluble epoxide hydrolase deficiency on acute pancreatitis in mice

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Bettaieb, Ahmed ^a   Chahed, Samah ^a   Tabet, George ^a   Yang, Jun ^a,b   Morisseau, Christophe ^a,b   Griffey, Stephen ^a   Hammock, Bruce D ^a,b   Haj, Fawaz G ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Division of Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; EPOXIDE HYDROLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SOLUBLE EPOXIDE HYDROLASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; CERULETIDE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; INTRACELLULAR SIGNALING; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PANCREATITIS; PATHOLOGY; SIGNAL TRANSDUCTION;

MUS;

ACUTE DISEASE; ANIMALS; CELL DEATH; CERULETIDE; DISEASE MODELS, ANIMAL; EPOXIDE HYDROLASES; GENE EXPRESSION; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; NF-KAPPA B; PANCREATITIS;

EID: 84913527916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113019     Document Type: Article

References (54)

1. Pandol SJ, Saluja AK, Imrie CW, Banks PA (2007) Acute pancreatitis: bench to the bedside. Gastroenterology 132: 1127-1151
2. Jha RK, Ma Q, Sha H, Palikhe M (2009) Acute pancreatitis: A literature review. Med Sci Monit 15: RA147-156
3. Whitcomb DC (2006) Clinical practice. Acute pancreatitis. N Engl J Med 354: 2142-2150
4. Saluja AK, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbauer B, et al. (1997) Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113: 304-310
5. Bialek R, Willemer S, Arnold R, Adler G (1991) Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats. Scand J Gastroenterol 26: 190-196
6. Naruse S (2003) Molecular pathophysiology of pancreatitis. Intern Med 42: 288-289
7. Lerch MM, Gorelick FS (2013) Models of acute and chronic pancreatitis. Gastroenterology 144: 1180-1193
8. Sato S, Stark HA, Martinez J, Beaven MA, Jensen RT, et al. (1989) Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Am J Physiol 257: G202-209
9. Willemer S, Elsasser HP, Adler G (1992) Hormone-induced pancreatitis. Eur Surg Res 24 Suppl 1: 29-39
10. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ (1998) Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 275: G1402-1414
11. Lim JW, Kim KH, Kim H (2008) NF-kappaB p65 regulates nuclear translocation of Ku70 via degradation of heat shock cognate protein 70 in pancreatic acinar AR42J cells. Int J Biochem Cell Biol 40: 2065-2077
12. Norman J (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175: 76-83
13. Pereda J, Sabater L, Aparisi L, Escobar J, Sandoval J, et al. (2006) Interaction between cytokines and oxidative stress in acute pancreatitis. Curr Med Chem 13: 2775-2787
14. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, et al. (1991) Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101: 782-785
15. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288
16. Yang F, Tang E, Guan K, Wang CY (2003) IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 170: 5630-5635
17. Gill SS, Hammock BD (1980) Distribution and properties of a mammalian soluble epoxide hydrase. Biochem Pharmacol 29: 389-395
18. Enayetallah AE, French RA, Thibodeau MS, Grant DF (2004) Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52: 447-454
19. Spector AA, Norris AW (2007) Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292: C996-1012
20. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, et al. (2000) Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87: 992-998
21. Morisseau C, Hammock BD (2013) Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 53: 37-58
22. Inceoglu B, Schmelzer KR, Morisseau C, Jinks SL, Hammock BD (2007) Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat 82: 42-49
23. Imig JD, Hammock BD (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 8: 794-805
24. Luria A, Bettaieb A, Xi Y, Shieh GJ, Liu HC, et al. (2011) Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci U S A 108: 9038-9043
25. Inceoglu B, Wagner KM, Yang J, Bettaieb A, Schebb NH, et al. (2012) Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes. Proc Natl Acad Sci U S A 109: 11390-11395
26. Zhang W, Liao J, Li H, Dong H, Bai H, et al. (2013) Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency. Mol Carcinog 52: 726-738
27. Sirish P, Li N, Liu JY, Lee KS, Hwang SH, et al. (2013) Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis. Proc Natl Acad Sci U S A 110: 5618-5623
28. Shen HC, Hammock BD (2012) Discovery of inhibitors of soluble epoxide hydrolase: A target with multiple potential therapeutic indications. J Med Chem 55: 1789-1808
29. Node K, Huo Y, Ruan X, Yang B, Spiecker M, et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279
30. Chiamvimonvat N, Ho CM, Tsai HJ, Hammock BD (2007) The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 50: 225-237
31. Luo P, Chang HH, Zhou Y, Zhang S, Hwang SH, et al. (2010) Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis. J Pharmacol Exp Ther 334: 430-438
32. Chen L, Fan C, Zhang Y, Bakri M, Dong H, et al. (2013) Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. Prostaglandins Other Lipid Mediat 104-105: 42-48
33. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, et al. (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275: 40504-40510
34. Dawra R, Sharif R, Phillips P, Dudeja V, Dhaulakhandi D, et al. (2007) Development of a new mouse model of acute pancreatitis induced by administration of L-arginine. Am J Physiol Gastrointest Liver Physiol 292: G1009-1018
35. Yang J, Bratt J, Franzi L, Liu J, Zhang G, et al. (2014) Soluble Epoxide Hydrolase Inhibitor Attenuates Inflammation and Airway Hyperresponsiveness in Mice. Am J Respir Cell Mol Biol
36. Yang J, Schmelzer K, Georgi K, Hammock BD (2009) Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem 81: 8085-8093
37. Sarmiento N, Sanchez-Bernal C, Ayra M, Perez N, Hernandez-Hernandez A, et al. (2008) Changes in the expression and dynamics of SHP-1 and SHP-2 during cerulein-induced acute pancreatitis in rats. Biochim Biophys Acta 1782: 271-279
38. Bettaieb A, Xi Y, Hosein E, Coggins N, Bachaalany S, et al. (2014) Pancreatic T cell protein-tyrosine phosphatase deficiency ameliorates cerulein-induced acute pancreatitis. Cell Commun Signal 12: 13
39. Baumann B, Wagner M, Aleksic T, von Wichert G, Weber CK, et al. (2007) Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest 117: 1502-1513
40. Chen X, Ji B, Han B, Ernst SA, Simeone D, et al. (2002) NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 122: 448-457
41. Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, Pandol SJ (2001) Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 280: G1197-1208
42. Schafer C, Williams JA (2000) Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease. J Gastroenterol 35: 1-9
43. Morin C, Sirois M, Echave V, Albadine R, Rousseau E (2010) 17,18- epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase. Am J Respir Cell Mol Biol 43: 564-575
44. Fischer U, Janicke RU, Schulze-Osthoff K (2003) Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ 10: 76-100
45. Dahmer MK (2005) Caspases-2, -3, and -7 are involved in thapsigargin-induced apoptosis of SH-SY5Y neuroblastoma cells. J Neurosci Res 80: 576-583
46. Ji B, Chen XQ, Misek DE, Kuick R, Hanash S, et al. (2003) Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator. Physiol Genomics 14: 59-72
47. Bettaieb A, Nagata N, AbouBechara D, Chahed S, Morisseau C, et al. (2013) Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue. J Biol Chem 288: 14189-14199
48. Bae GS, Kim MS, Jeong J, Lee HY, Park KC, et al. (2011) Piperine ameliorates the severity of cerulein-induced acute pancreatitis by inhibiting the activation of mitogen activated protein kinases. Biochem Biophys Res Commun 410: 382-388
49. Zhang XP, Zhang L, Wang Y, Cheng QH, Wang JM, et al. (2007) Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis. JOP 8: 400-412
50. Wagner AC, Metzler W, Hofken T, Weber H, Goke B (1999) p38 map kinase is expressed in the pancreas and is immediately activated following cerulein hyperstimulation. Digestion 60: 41-47
51. Hofken T, Keller N, Fleischer F, Goke B, Wagner AC (2000) Map kinase phosphatases (MKP's) are early responsive genes during induction of cerulein hyperstimulation pancreatitis. Biochem Biophys Res Commun 276: 680-685
52. Tapia JA, Ferris HA, Jensen RT, Garcia LJ (1999) Cholecystokinin activates PYK2/CAKbeta by a phospholipase C-dependent mechanism and its association with the mitogen-activated protein kinase signaling pathway in pancreatic acinar cells. J Biol Chem 274: 31261-31271
53. Minutoli L, Altavilla D, Marini H, Passaniti M, Bitto A, et al. (2004) Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of ceruleininduced pancreatitis. Life Sci 75: 2853-2866
54. Lugea A, Tischler D, Nguyen J, Gong J, Gukovsky I, et al. (2011) Adaptive unfolded protein response attenuates alcohol-induced pancreatic damage. Gastroenterology 140: 987-997